ITOS Revenue and Competitors

Chicago, IL USA

Location

N/A

Total Funding

HR

Industry

Estimated Revenue & Valuation

  • ITOS's estimated annual revenue is currently $27.1M per year.(i)
  • ITOS's estimated revenue per employee is $201,000

Employee Data

  • ITOS has 135 Employees.(i)
  • ITOS grew their employee count by 10% last year.

ITOS's People

NameTitleEmail/Phone
1
Founder & CEOReveal Email/Phone
2
Director de OperacionesReveal Email/Phone
3
Project Manager JrReveal Email/Phone
4
Country/Oper. Manager BrazilReveal Email/Phone
5
OPERATIONS MANAGERReveal Email/Phone
6
Client Account ManagerReveal Email/Phone
7
Operations SupervisorReveal Email/Phone
8
Analista de RH Customer SuccessReveal Email/Phone
9
Operations supervisorReveal Email/Phone
10
Payroll AssistantReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$3.9M288%N/AN/A
#2
$3.7M260%N/AN/A
#3
$3.8M274%N/AN/A
#4
$23.1M11521%N/AN/A
#5
$0.7M7N/AN/AN/A
#6
$19.5M97-3%N/AN/A
#7
$7.9M490%N/AN/A
#8
$53.1M24020%N/AN/A
#9
$20.3M101-9%N/AN/A
#10
$105.8M4216%N/AN/A
Add Company

What Is ITOS?

ITOS is an international Business alliance of service companies offering fully integrated HR and Payroll solutions that promote collaboration, connectivity and communication throughout an organization. Legendary HR. We have been selected by many multinational companies to manage their payrolls and HR processes in 22+ Countries. ITOS works closely with clients in the oil, communications, raw material, real estate, energy, technology, financial, computer and services industries.

keywords:N/A

N/A

Total Funding

135

Number of Employees

$27.1M

Revenue (est)

10%

Employee Growth %

N/A

Valuation

N/A

Accelerator

ITOS News

2022-04-17 - Michel Detheux Sells 11500 Shares of iTeos Therapeutics, Inc ...

(NASDAQ:ITOS – Get Rating) CEO Michel Detheux sold 11,500 shares of the firm's stock in a transaction dated Monday, April 18th. The stock was...

2022-04-17 - $0.82 Earnings Per Share Expected for iTeos Therapeutics ...

(NASDAQ:ITOS – Get Rating) will post earnings of $0.82 per share for the current fiscal quarter, Zacks Investment Research reports. Four...

2022-04-13 - Is it Time to Dump iTeos Therapeutics Inc (ITOS) Stock After it Is Up 1.24% in a Week?

ITOS gets a Bullish score from InvestorsObserver Stock Sentiment Indicator. Sentiment Score - ,bullish. iTeos Therapeutics Inc has a Bullish...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$28.6M1367%N/A
#2
$15M1386%N/A
#3
$28.5M142-15%N/A
#4
$23M144-1%N/A
#5
$15M14433%N/A